ZIMHI Drug Patent Profile
✉ Email this page to a colleague
When do Zimhi patents expire, and when can generic versions of Zimhi launch?
Zimhi is a drug marketed by Adamis Pharms Corp and is included in one NDA. There are two patents protecting this drug.
This drug has ten patent family members in nine countries.
The generic ingredient in ZIMHI is naloxone hydrochloride. There are twelve drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zimhi
A generic version of ZIMHI was approved as naloxone hydrochloride by HOSPIRA on September 24th, 1986.
Summary for ZIMHI
International Patents: | 10 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 1,792 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZIMHI |
What excipients (inactive ingredients) are in ZIMHI? | ZIMHI excipients list |
DailyMed Link: | ZIMHI at DailyMed |
Pharmacology for ZIMHI
Drug Class | Opioid Antagonist |
Mechanism of Action | Opioid Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for ZIMHI
US Patents and Regulatory Information for ZIMHI
ZIMHI is protected by four US patents.
Patents protecting ZIMHI
Emergency devices
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF AN OPIOID ANTAGONIST COMPRISING AN EMERGENCY SYRINGE DEVICE
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF AN OPIOID ANTAGONIST COMPRISING AN EMERGENCY SYRINGE DEVICE INCLUDING A NEEDLE GUARD
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: A METHOD FOR ADMINISTERING A THERAPEUTIC DOSE OF AN OPIOID ANTAGONIST COMPRISING AN EMERGENCY SYRINGE DEVICE INCLUDING A WINDOW CONFIGURED TO ALLOW THE USER TO VIEW THE OPIOID ANTAGONIST IN THE SYRINGE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adamis Pharms Corp | ZIMHI | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 212854-001 | Oct 15, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adamis Pharms Corp | ZIMHI | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 212854-001 | Oct 15, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZIMHI
See the table below for patents covering ZIMHI around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2021524328 | 緊急デバイス | ⤷ Try a Trial |
South Korea | 20210013617 | 응급 장치 | ⤷ Try a Trial |
Israel | 278999 | מכשירים לחירום (Emergency devices) | ⤷ Try a Trial |
European Patent Office | 3801699 | DISPOSITIFS D'URGENCE (EMERGENCY DEVICES) | ⤷ Try a Trial |
China | 112469458 | 紧急装置 (EMERGENCY DEVICES) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ZIMHI
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |